Search Login Register

Enoximone Summary

Description: A selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with CONGESTIVE HEART FAILURE.

Also Known As: Aventis Brand of Enoximone; Carinopharm Brand of Enoximone; Fenoximone; MDL 19438; MDL-17,043 Show All >>

Networked: 271 relevant articles (47 outcomes, 54 trials/studies) for this Bio-Agent

Key Diseases for which Enoximone is Relevant

  1. Heart Failure : 27 outcomes 35 studies in 157 results
  2. Cardiogenic Shock : 5 outcomes 3 studies in 14 results
  3. Stroke (Strokes) : 4 outcomes in 12 results
  4. Pulmonary Hypertension (Ayerza Syndrome) : 3 outcomes 1 study in 12 results
  5. Low Cardiac Output : 3 outcomes in 16 results
Show All >>

Drugs Related to Enoximone

  1. Dobutamine
  2. Vasodilator Agents (Vasodilators)
  3. Enoximone
  4. Nitroprusside (Sodium Nitroprusside)
  5. Nitroglycerin (Dynamite)
  6. simendan (Levosimendan)
  7. Diuretics
  8. esmolol (Brevibloc)
  9. Catecholamines
  10. Metoprolol (Lopressor)
Show All >>

Therapies Related to Enoximone

  1. Heart Transplantation (Grafting, Heart)
  2. Cardiopulmonary Bypass (Heart-Lung Bypass)
  3. Transplantation (Transplant Recipients)
  4. Counterpulsation (External Counterpulsation)
  5. Oral Administration
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.